147 related articles for article (PubMed ID: 31061751)
1. Acute Gaucher Disease-Like Condition in an Indian Infant with a Novel Biallelic Mutation in the Prosaposin Gene.
Radha Rama Devi A; Kadali S; Radhika A; Singh V; Kumar MA; Reddy GM; Naushad SM
J Pediatr Genet; 2019 Jun; 8(2):81-85. PubMed ID: 31061751
[TBL] [Abstract][Full Text] [Related]
2. Non-neuronopathic Gaucher disease due to saposin C deficiency.
Tylki-Szymańska A; Czartoryska B; Vanier MT; Poorthuis BJ; Groener JA; Ługowska A; Millat G; Vaccaro AM; Jurkiewicz E
Clin Genet; 2007 Dec; 72(6):538-42. PubMed ID: 17919309
[TBL] [Abstract][Full Text] [Related]
3. A Type 3 Gaucher-Like Disease Due To Saposin C Deficiency in Two Emirati Families Caused by a Novel Splice Site Variant in the PSAP Gene.
Mohamed FE; Ali A; Al-Tenaiji A; Al-Jasmi A; Al-Jasmi F
J Mol Neurosci; 2022 Jun; 72(6):1322-1333. PubMed ID: 35316504
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and molecular characterization of adult patients with type I Gaucher disease and carrier frequency analysis of Leu444Pro - a common Gaucher disease mutation in India.
Sheth J; Pancholi D; Mistri M; Nath P; Ankleshwaria C; Bhavsar R; Puri R; Phadke S; Sheth F
BMC Med Genet; 2018 Oct; 19(1):178. PubMed ID: 30285649
[TBL] [Abstract][Full Text] [Related]
5. A rare form of Gaucher disease resulting from saposin C deficiency.
Kang L; Zhan X; Ye J; Han L; Qiu W; Gu X; Zhang H
Blood Cells Mol Dis; 2018 Feb; 68():60-65. PubMed ID: 28457694
[TBL] [Abstract][Full Text] [Related]
6. The role of saposin C in Gaucher disease.
Tamargo RJ; Velayati A; Goldin E; Sidransky E
Mol Genet Metab; 2012 Jul; 106(3):257-63. PubMed ID: 22652185
[TBL] [Abstract][Full Text] [Related]
7. Phenotype Expansion for Atypical Gaucher Disease Due to Homozygous Missense PSAP Variant in a Large Consanguineous Pakistani Family.
Liaqat K; Hussain S; Acharya A; Nasir A; Bharadwaj T; Ansar M; Basit S; Schrauwen I; Ahmad W; Leal SM
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456468
[TBL] [Abstract][Full Text] [Related]
8. Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations.
Kuchar L; Ledvinová J; Hrebícek M; Mysková H; Dvoráková L; Berná L; Chrastina P; Asfaw B; Elleder M; Petermöller M; Mayrhofer H; Staudt M; Krägeloh-Mann I; Paton BC; Harzer K
Am J Med Genet A; 2009 Feb; 149A(4):613-21. PubMed ID: 19267410
[TBL] [Abstract][Full Text] [Related]
9. Combined saposin deficiency: A rare occurrence.
Bhat V; Thergaonkar RW; Thakur M; Rajkamal T
Med J Armed Forces India; 2023; 79(2):238-240. PubMed ID: 36969110
[TBL] [Abstract][Full Text] [Related]
10. A mutation in the saposin C domain of the sphingolipid activator protein (Prosaposin) gene causes neurodegenerative disease in mice.
Yoneshige A; Suzuki K; Suzuki K; Matsuda J
J Neurosci Res; 2010 Aug; 88(10):2118-34. PubMed ID: 20175216
[TBL] [Abstract][Full Text] [Related]
11. Prosaposin deficiency: further characterization of the sphingolipid activator protein-deficient sibs. Multiple glycolipid elevations (including lactosylceramidosis), partial enzyme deficiencies and ultrastructure of the skin in this generalized sphingolipid storage disease.
Bradová V; Smíd F; Ulrich-Bott B; Roggendorf W; Paton BC; Harzer K
Hum Genet; 1993 Sep; 92(2):143-52. PubMed ID: 8370580
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia and GBA gene mutation in a patient with adult type 1 Gaucher disease.
Wan L; Wu H; Xie F; Nie Y
Platelets; 2017 Dec; 28(8):829-831. PubMed ID: 28580830
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic characteristics of Gaucher disease according to phenotypic subgroups.
Lee JY; Lee BH; Kim GH; Jung CW; Lee J; Choi JH; Yoo HW
Korean J Pediatr; 2012 Feb; 55(2):48-53. PubMed ID: 22375149
[TBL] [Abstract][Full Text] [Related]
14. Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis.
Giacomarra M; Colomba P; Francofonte D; Zora M; Caocci G; Diomede D; Giuffrida G; Fiori L; Montanari C; Sapuppo A; Scortechini AR; Vitturi N; Duro G; Zizzo C
J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592326
[No Abstract] [Full Text] [Related]
15. A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity.
Diaz-Font A; Cormand B; Santamaria R; Vilageliu L; Grinberg D; Chabás A
Hum Genet; 2005 Jul; 117(2-3):275-7. PubMed ID: 15856305
[TBL] [Abstract][Full Text] [Related]
16. [Prenatal diagnosis of Gaucher disease].
Germain DP; Benistan K
Rev Med Interne; 2007 Oct; 28 Suppl 2():S193-7. PubMed ID: 18240370
[TBL] [Abstract][Full Text] [Related]
17. Late Infantile Metachromatic Leukodystrophy Due to Novel Pathogenic Variants in the PSAP Gene.
Kolnikova M; Jungova P; Skopkova M; Foltan T; Gasperikova D; Mattosova S; Chandoga J
J Mol Neurosci; 2019 Apr; 67(4):559-563. PubMed ID: 30632081
[TBL] [Abstract][Full Text] [Related]
18. Neuronopathic Gaucher disease presenting with microcytic hypochromic anemia.
Kim EA; Lim YT; Hah JO; Sohn YB; Kim YK; Choi JH; Kim SY; Jang KM; Ahn J; Lee JM
Int J Hematol; 2019 Mar; 109(3):361-365. PubMed ID: 30456712
[TBL] [Abstract][Full Text] [Related]
19. Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene.
Tayebi N; Cushner SR; Kleijer W; Lau EK; Damschroder-Williams PJ; Stubblefield BK; Den Hollander J; Sidransky E
Am J Med Genet; 1997 Nov; 73(1):41-7. PubMed ID: 9375921
[TBL] [Abstract][Full Text] [Related]
20. Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking.
Sun Y; Witte DP; Zamzow M; Ran H; Quinn B; Matsuda J; Grabowski GA
Hum Mol Genet; 2007 Apr; 16(8):957-71. PubMed ID: 17353235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
